# clm_FBBAE356E784

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_net_income  
value: -62,365,000 United States dollar  
valid_from: 2011-09-30  
valid_to: 2012-03-31  
published: 2011-10-27  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_DE7CE27F0752  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly net income: -62,365,000 United States dollar", as of 2011-09-30 (until 2012-03-31). Claim clm_FBBAE356E784, https://asof.is/claim/clm_FBBAE356E784, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677411002300/0001206774-11-002300-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q3 FY2011, filed 2011-10-27  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677411002300/0001206774-11-002300-index.htm (primary, SEC EDGAR 10-Q Q3 FY2011, published 2011-10-27)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | -62,505,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_FBBAE356E784](/claim/clm_FBBAE356E784.md) | [clm_BEE2EE1A4F91](/claim/clm_BEE2EE1A4F91.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.